Welcome to Labeled Immunoassays and Clinical Medicine website!

Correlation of Risk Stratification of Acute Coronary Syndrome with Serum Myocardial Markers

Expand
  • Clinical laboratory Center, Traditional Chinese Medicine Hospital Affiliated to Xinjiang Medical University,Urumqi 830000, China

Received date: 2013-06-24

  Revised date: 2013-09-10

  Online published: 2014-07-15

Abstract

Abstract: Objective To explore the correlation of risk stratification of acute coronary syndrome(ACS)with ischemia modified albumin (IMA), heart fatty acid binding protein (H-FABP) and uric acid. Methods 70 patients were divided into unstable angina pectoris (UAP), ST-elevation myocardial infarction (STEMI) and non ST-elevation myocardial infarction (NSTEMI) group based on ACS standard. They were divided into low-risk, Intermediate-risk and high-risk groups based on GRACE risk score. Results 22 (31%) patients were admitted for UAP, 17 (24%) for NSTEMI, and 32 (45%) for STEMI. There were significantly difference in hospital mortality risk score and hospital mortality between UAP and NSTMEI groups (P<0.05). The hospital mortality in STEMI group had significantly difference between low and high-risk group (P<0.05). There were no significantly difference for serum H-FABP and UA levels in three groups (P>0.05). The serum IMA had clearly difference between low and high-risk group in NSTMEI (P<0.01). Conclusion Hospital mortality risk score and hospital mortality play an important role in GRACE to indicate the disease severity. The serum H-FABP, IMA and UA levels cannot be considered as the indexes to judge the degree of ACS.

Cite this article

YANG Li, PENG Hui, LIU Qin, LI Xiao-zheng, QIAO Li, LIN Yu-wei, MA Jun-jie, XIE Kun, XU Fei-li . Correlation of Risk Stratification of Acute Coronary Syndrome with Serum Myocardial Markers[J]. Labeled Immunoassays and Clinical Medicine, 2014 , 21(2) : 127 -131 . DOI: 10.11748/bjmy.issn.1006-1703.2014.02.006

Options
Outlines

/